BLISS GVS PHARMA
Back to All Ratios
|
BLISS GVS PHARMA Last 5 Year Core EBITDA Margin History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Core EBITDA Margin(%) | 19.34 | 15.61 | 15.83 | 18.48 | 17.89 |
What is the latest Core EBITDA Margin ratio of BLISS GVS PHARMA ?
Year | Core EBITDA Margin |
---|---|
Mar2024 | 19.34 |
Mar2023 | 15.61 |
Mar2022 | 15.83 |
Mar2021 | 18.48 |
Mar2020 | 17.89 |
How is Core EBITDA Margin of BLISS GVS PHARMA Trending?
Years | Core EBITDA Margin | % Change | |
---|---|---|---|
Mar2024 | 19.34 | 23.89 | |
Mar2023 | 15.61 | -1.39 | |
Mar2022 | 15.83 | -14.34 | |
Mar2021 | 18.48 | 3.30 | |
Mar2020 | 17.89 | - |
Other Financial Ratios of BLISS GVS PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Margin ratio of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,575.2 Cr | 10.7% | 14.7% | 43% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,809.0 Cr | 1.4% | -0.8% | 13.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,808.0 Cr | 1.4% | -1.7% | 45.3% | Stock Analytics | |
CIPLA | ₹121,964.0 Cr | 1.8% | 2% | -2.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,905.0 Cr | 1.1% | 7.9% | 11.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,174.0 Cr | 1.8% | 1.6% | 12.3% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | 10.7% |
14.7% |
43% |
SENSEX | 1.6% |
0.7% |
6.8% |
You may also like the below Video Courses